Cargando…
Which Therapy for Non-Type(T)2/T2-Low Asthma
Currently, the asthmatic population is divided into Type 2-high and non-Type 2/Type 2-low asthmatics, with 50% of patients belonging to one of the two groups. Differently from T2-high, T2-low asthma has not been clearly defined yet, and the T2-low patients are identified on the basis of the absence...
Autores principales: | Ricciardolo, Fabio L. M., Carriero, Vitina, Bertolini, Francesca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779705/ https://www.ncbi.nlm.nih.gov/pubmed/35055325 http://dx.doi.org/10.3390/jpm12010010 |
Ejemplares similares
-
The Role of Dupilumab in Severe Asthma
por: Ricciardolo, Fabio Luigi Massimo, et al.
Publicado: (2021) -
Phenotype overlap in the natural history of asthma
por: Ricciardolo, Fabio L.M., et al.
Publicado: (2023) -
Characterization of T2-Low and T2-High Asthma Phenotypes in Real-Life
por: Ricciardolo, Fabio Luigi Massimo, et al.
Publicado: (2021) -
Reliability of Total Serum IgE Levels to Define Type 2 High and Low Asthma Phenotypes
por: Guida, Giuseppe, et al.
Publicado: (2023) -
MicroRNAs as Biomarkers in Corticosteroid-Resistant/Neutrophilic
Asthma: Still a Long Way to Go!
por: Ricciardolo, Fabio L. M., et al.
Publicado: (2020)